Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company AmVac AG
DescriptionVector-based vaccine that expresses RSV antigens using the Sendai virus vector platform
Molecular Target
Mechanism of Action 
Therapeutic ModalityPreventive vaccine: Viral vaccine
Latest Stage of DevelopmentPreclinical
Standard IndicationRespiratory syncytial virus (RSV)
Indication DetailsPrevent respiratory syncytial virus (RSV)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today